Through monitoring minimal residual disease (MRD), we can assess and predict the recurrence risk more than 3 months earlier than radiological recurrence prediction on average.
Professional medical assistants and scheduled follow-ups are available to our patients during their treatment and convalescence.
Condition changes are closely monitored to support timely detection of the recurrence risk.
A patient shall purchase
the testing service through
a physician and sign the ICF.
We can provide medical history
and records, discharge records,
and imaging materials, etc.
We can recommend similar
treatment cases to the patients to
provide more information on disease
treatment from a multi-dimensional
and visualized perspective.
We can evaluate the treatment
prognosis, and track the
follow-up treatment and
re-examination, until loss
of follow-up.
5th Floor, Building 3, 115 Xinjun Ring Road, Minhang District, Shanghai
Floor 4, Information Building 2, Zhaolou Road 3576 , Pujiang Town, Minhang District, Shanghai
400-821-9890
Service Hours:9:00-18:00 Monday to Friday (except statutory holidays)
zbservice@origimed.com
We will reply you as soon as we receive the email.
All rights reserved in ? Copyright 2022 OrigiMed Ltd
Registration Number:滬ICP備16027109號-1